Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 10.47
+0.15 (1.45%)
At close: Sep 30, 2026
| Market Cap | 4.11B -17.6% |
| Revenue (ttm) | 710.55M +3.2% |
| Net Income | 103.98M -25.8% |
| EPS | 0.27 -25.7% |
| Shares Out | 392.08M |
| PE Ratio | 39.38 |
| Forward PE | n/a |
| Dividend | 0.20 (1.91%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 3,693,110 |
| Open | 10.32 |
| Previous Close | 10.32 |
| Day's Range | 10.32 - 10.57 |
| 52-Week Range | 8.45 - 13.84 |
| Beta | 0.18 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |